aminolevulinic acid has been researched along with alpha-Thalassemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Shioda, N; Suzuki, S; Wada, T | 1 |
Era, T; Fukunaga, K; Kurosawa, K; Li, Y; Okamoto, N; Onozato, M; Shioda, N; Sugiyama, H; Tanabe, H; Wada, T; Yabuki, Y; Yamaguchi, K | 1 |
2 other study(ies) available for aminolevulinic acid and alpha-Thalassemia
Article | Year |
---|---|
5-Aminolevulinic acid can ameliorate language dysfunction of patients with ATR-X syndrome.
Topics: Alleles; alpha-Thalassemia; Amino Acid Substitution; Aminolevulinic Acid; Ataxia Telangiectasia Mutated Proteins; Child, Preschool; Genotype; Humans; Language Disorders; Male; Mental Retardation, X-Linked; Mutation | 2020 |
Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome.
Topics: 3' Untranslated Regions; alpha-Thalassemia; Aminolevulinic Acid; Animals; Brain; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cognition; Cytoplasmic Granules; Cytoskeletal Proteins; Dendrites; DNA; G-Quadruplexes; Ligands; Male; Mental Retardation, X-Linked; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Nuclear Proteins; Protein Binding; RNA Polymerase II; RNA Transport; RNA, Messenger; Transcription, Genetic | 2018 |